Healthcare provider profile · identity verified

Albert S Oh, MD

Internal Medicine · CLACKAMAS, OR · NPI 1396718912

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	825	241
Lisinopril	Lisinopril	551	166
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	450	127
Amlodipine Besylate	Amlodipine Besylate	390	119
Losartan Potassium	Losartan Potassium	388	119
Simvastatin	Simvastatin	331	96
Levothyroxine Sodium	Levothyroxine Sodium	274	72
Oxycodone Hcl	Oxycodone Hcl	252	89
Atenolol	Atenolol	245	71
Metoprolol Tartrate	Metoprolol Tartrate	224	76
Pantoprazole Sodium	Pantoprazole Sodium	208	81
Trazodone Hcl	Trazodone Hcl	206	66
Tamsulosin Hcl	Tamsulosin Hcl	205	69
Albuterol Sulfate Hfa	Albuterol Sulfate	183	86
Pradaxa	Dabigatran Etexilate Mesylate	168	53
Gabapentin	Gabapentin	165	57
Metformin Hcl	Metformin Hcl	158	52
Potassium Chloride	Potassium Chloride	156	52
Glipizide	Glipizide	152	47
Rosuvastatin Calcium	Rosuvastatin Calcium	129	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	128	39
Hydrochlorothiazide	Hydrochlorothiazide	116	39
Metformin Hcl Er	Metformin Hcl	112	39
Morphine Sulfate Er	Morphine Sulfate	106	20
Allopurinol	Allopurinol	105	32
Donepezil Hcl	Donepezil Hcl	104	25
Furosemide	Furosemide	104	34
Meloxicam	Meloxicam	99	40
Metoprolol Succinate	Metoprolol Succinate	89	33
Finasteride	Finasteride	86	31
Fluticasone Propionate	Fluticasone Propionate	82	31
Spironolactone	Spironolactone	82	31
Carvedilol	Carvedilol	76	20
Sertraline Hcl	Sertraline Hcl	76	29
Fluoxetine Hcl	Fluoxetine Hcl	74	26
Clopidogrel	Clopidogrel Bisulfate	69	24
Alendronate Sodium	Alendronate Sodium	68	28
Spiriva Respimat	Tiotropium Bromide	68	21
Lorazepam	Lorazepam	63	26
Warfarin Sodium	Warfarin Sodium	63	20
Omeprazole	Omeprazole	60	25
Famotidine	Famotidine	59	14
Venlafaxine Hcl Er	Venlafaxine Hcl	58	20
Mirtazapine	Mirtazapine	57	15
Pravastatin Sodium	Pravastatin Sodium	56	19
Humulin N	Insulin Nph Human Isophane	55	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	18
Wixela Inhub	Fluticasone Propion/Salmeterol	54	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	25
Alvesco	Ciclesonide	52	19
Montelukast Sodium	Montelukast Sodium	51	15
Acetaminophen-Codeine	Acetaminophen With Codeine	50	11
Terazosin Hcl	Terazosin Hcl	48	15
Tramadol Hcl	Tramadol Hcl	45	15
Duloxetine Hcl	Duloxetine Hcl	44	12
Bupropion Xl	Bupropion Hcl	43	15
Quetiapine Fumarate	Quetiapine Fumarate	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	41	16
Pioglitazone Hcl	Pioglitazone Hcl	40	12
Buspirone Hcl	Buspirone Hcl	35	14
Prednisone	Prednisone	35	21
Triamcinolone Acetonide	Triamcinolone Acetonide	35	19
Jardiance	Empagliflozin	34	12
Ondansetron Odt	Ondansetron	34	15
Paxlovid	Nirmatrelvir/Ritonavir	34	34
Propranolol Hcl	Propranolol Hcl	34	11
Humulin R	Insulin Regular, Human	33	13
Lovastatin	Lovastatin	33	11
Escitalopram Oxalate	Escitalopram Oxalate	32	13
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Eliquis	Apixaban	31	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Acyclovir	Acyclovir	28	12
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Torsemide	Torsemide	28	11
Morphine Sulfate	Morphine Sulfate	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Alprazolam	Alprazolam	24	17
Azithromycin	Azithromycin	24	13
Pregabalin	Pregabalin	24	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	24	suppressed
Hydrocortisone	Hydrocortisone	23	19
Methocarbamol	Methocarbamol	23	suppressed
Oxycontin	Oxycodone Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	21	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Estradiol	Estradiol	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Baclofen	Baclofen	18	suppressed
Cefadroxil	Cefadroxil	18	17
Veo Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Amoxicillin	Amoxicillin	16	14
Naproxen	Naproxen	16	suppressed
Nitroglycerin	Nitroglycerin	16	13
Ibuprofen	Ibuprofen	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	12
Nifedipine Er	Nifedipine	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	15
Colchicine	Colchicine	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lactulose	Lactulose	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Sure Comfort Pen Needle	Pen Needle, Diabetic	14	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	14	14
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	13	13
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Nystatin	Nystatin	12	suppressed
Risperidone	Risperidone	12	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	12	12
Clonidine Hcl	Clonidine Hcl	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error